Acute Promyelocytic Leukemia Presenting with Cranial Nerve Involvement and Clivus Mass.

IF 1.1 4区 医学 Q3 HEMATOLOGY Acta Haematologica Pub Date : 2025-03-29 DOI:10.1159/000545444
Ananya Chandrika Nanduri, Farah Ashraf, Swe Swe Hlaing, Michael Brister, Tapan M Kadia, Naveen Pemmaraju, Tulin Budak-Alpdogan
{"title":"Acute Promyelocytic Leukemia Presenting with Cranial Nerve Involvement and Clivus Mass.","authors":"Ananya Chandrika Nanduri, Farah Ashraf, Swe Swe Hlaing, Michael Brister, Tapan M Kadia, Naveen Pemmaraju, Tulin Budak-Alpdogan","doi":"10.1159/000545444","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukemia that has become highly curable with advances in targeted therapy. However, central nervous system (CNS) involvement is exceedingly rare in APL and presents significant therapeutic challenges due to the limited penetrance of standard therapies across the blood-brain barrier (BBB). While APL is traditionally managed without chemotherapy, cases with CNS involvement require a multimodal approach for effective disease control.</p><p><strong>Case presentation: </strong>We present a unique case of a 31-year-old male with de novo APL and CNS involvement at the presentation, including a clival mass. The patient was successfully treated with a combination of systemic chemotherapy, intrathecal chemotherapy, and craniospinal irradiation, leading to durable remission.</p><p><strong>Conclusion: </strong>This case highlights the rarity of CNS involvement in APL and underscores the importance of a multidisciplinary approach in its management. Additionally, it emphasizes the need to address logistical barriers to treatment to achieve optimal patient outcomes.</p>","PeriodicalId":6981,"journal":{"name":"Acta Haematologica","volume":" ","pages":"1-7"},"PeriodicalIF":1.1000,"publicationDate":"2025-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Haematologica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000545444","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukemia that has become highly curable with advances in targeted therapy. However, central nervous system (CNS) involvement is exceedingly rare in APL and presents significant therapeutic challenges due to the limited penetrance of standard therapies across the blood-brain barrier (BBB). While APL is traditionally managed without chemotherapy, cases with CNS involvement require a multimodal approach for effective disease control.

Case presentation: We present a unique case of a 31-year-old male with de novo APL and CNS involvement at the presentation, including a clival mass. The patient was successfully treated with a combination of systemic chemotherapy, intrathecal chemotherapy, and craniospinal irradiation, leading to durable remission.

Conclusion: This case highlights the rarity of CNS involvement in APL and underscores the importance of a multidisciplinary approach in its management. Additionally, it emphasizes the need to address logistical barriers to treatment to achieve optimal patient outcomes.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
以脑神经受累和斜坡肿块为表现的急性早幼粒细胞白血病。
急性早幼粒细胞白血病(APL)是急性髓性白血病的一种独特亚型,随着靶向治疗的进展,这种白血病已经变得高度可治愈。然而,中枢神经系统(CNS)受损伤在APL中极为罕见,并且由于标准疗法通过血脑屏障(BBB)的外显率有限,这给治疗带来了重大挑战。虽然APL传统上不需要化疗,但累及中枢神经系统的病例需要多模式方法来实现有效的疾病控制。我们提出一个独特的病例,31岁男性APL和CNS的新发累及,包括一个斜坡肿块。患者成功地接受了全身化疗、鞘内化疗和颅脊髓照射的联合治疗,获得了持久的缓解。该病例强调了APL中中枢神经系统参与的罕见性,多学科方法的重要性,以及解决治疗的后勤障碍以实现最佳结果的必要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Acta Haematologica
Acta Haematologica 医学-血液学
CiteScore
4.90
自引率
0.00%
发文量
61
审稿时长
6-12 weeks
期刊介绍: ''Acta Haematologica'' is a well-established and internationally recognized clinically-oriented journal featuring balanced, wide-ranging coverage of current hematology research. A wealth of information on such problems as anemia, leukemia, lymphoma, multiple myeloma, hereditary disorders, blood coagulation, growth factors, hematopoiesis and differentiation is contained in first-rate basic and clinical papers some of which are accompanied by editorial comments by eminent experts. These are supplemented by short state-of-the-art communications, reviews and correspondence as well as occasional special issues devoted to ‘hot topics’ in hematology. These will keep the practicing hematologist well informed of the new developments in the field.
期刊最新文献
Improving cure rates of B-cell acute lymphoblastic leukemia with chimeric antigen receptor T-cells. Post-transplant lymphoproliferative disorder (PTLD) following heart transplantation presenting as a retroperitoneal plasmacytoma - a case report and review of the literature. A case series of SGLT2i improving hemoglobin in adults with myelodysplastic syndrome. Title: Hans-based cell of origin is not of prognostic significance in DLBCL patients; Retrospective single center study conducted in 326 RCHOP treated patients. Anexelekto (Axl)/Mer inhibitor tamnorzatinib in patients with relapsed/refractory acute myeloid leukaemia: Results from a phase I (monotherapy) and phase II (combination with venetoclax) clinical study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1